JPRN-UMIN000023803尚未招募2 期
Phase II clinical trial of multidisciplinary therapy using risk classification based on residual tumor volume and WHO grading for pediatric ependymoma patients (JCCG EPN1501) - Phase II clinical trial of multidisciplinary therapy for pediatric ependymoma patients( JCCG EPN1501)
The Japan Children's Cancer Group(JCCG)0 个研究点目标入组 40 人开始时间: 2016年10月20日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Synchronous or an asynchronous(within 5 years) other cancer 2)Existing heart disease to be treated 3)Pregnant or during breast-feeding 4)Inappropriate inclusion judged by attending physician
研究者
相似试验
已完成
2 期
Multi-center, phase II study for combination therapy with weekly pacritaxel and 5'-DFUR in patients with unresectable or recurrent gastric cancerAdvanced or recurrent gastric cancerJPRN-UMIN000008631Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine45
已完成
不适用
A study to evaluate the safety and tolerability of doxorubicin and durvalumab, in patients with advanced soft tissue sarcoma.KCT0003577Yonsei University Health System, Severance Hospital45
招募中
2 期
Multicenter phase2 clinical trial of tailored therapy according to MGMT methylation status for elderly glioblastoma patientsElderly glioblastomaJPRN-UMIN000012172Saitama Medical University International Medical Center70
进行中（未招募）
不适用
trial evaluating the efficacy of omalizumab (Xolair ®) in idiopathic refractory severe solar urticariaEUCTR2013-004910-16-FRCentre Hospitalier régional Universitaire de Besançon
进行中（未招募）
2 期
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30